Filters (1)
Filters

European Marine Science 030220 oncology & carcinogenesis

Filters

European Marine Science 030220 oncology & carcinogenesis

The following results are related to European Marine Science. Are you interested to view more results? Visit OpenAIRE - Explore.
Download Results
845 research outcomes, page 1 of 85
  • publication . Article . 2019
    Closed Access
    Authors:
    Adam, Salome; Koch‐Gallenkamp, Lena; Bertram, Heike; Eberle, Andrea; Holleczek, Bernd; Pritzkuleit, Ron; Waldeyer‐Sauerland, Mechthild; Waldmann, Annika; Zeissig, Sylke Ruth; Rohrmann, Sabine; ...
    Persistent Identifiers
    Publisher: Wiley

    OBJECTIVE Several therapies for localised prostate cancer (PC) are available; all yield similar survival rates. However, each therapy has significant side effects that can influence patients' health-related quality of life (HRQoL) in the long run. METHODS The study samp...

    Add to ORCIDorcid
  • publication . Article . 2017
    Open Access
    Authors:
    P.N. Aguiar; L.A. Perry; J. Penny-Dimri; H. Babiker; H. Tadokoro; R.A. de Mello; G.L. Lopes;
    Publisher: Elsevier BV
    Countries: Brazil, Portugal

    Made available in DSpace on 2019-08-19T11:48:40Z (GMT). No. of bitstreams: 0 Previous issue date: 2017 Background: Immune checkpoint inhibitors improve outcomes compared with chemotherapy in lung cancer. Tumor PD-L1 receptor expression is being studied as a predictive b...

    Add to ORCIDorcid
  • publication . Article . 2020
    Open Access English
    Authors:
    Radek Kucera; Ladislav Pecen; Ondrej Topolcan; Anshu Raj Dahal; Vincenzo Costigliola; Frank A. Giordano; Olga Golubnitschaja;
    Persistent Identifiers
    Publisher: Springer International Publishing

    AbstractIn the early twenty-first century, societies around the world are facing the paradoxal epidemic development of PCa as a non-communicable disease. PCa is the most frequently diagnosed cancer for men in several countries such as the USA. Permanently improving diag...

    Add to ORCIDorcid
  • publication . Article . Preprint . 2020
    Open Access
    Authors:
    Kumuditha M. Weerakoon-Ratnayake; Swarnagowri Vaidyanathan; Nicholas Larkey; Kavya Dathathreya; Mengjia Hu; Jilsha Jose; Shalee Mog; Keith J. August; Andrew K. Godwin; Mateusz L. Hupert; ...
    Publisher: MDPI AG
    Project: NIH | Increased sensitivity of ... (1R44CA224848-01A1), NIH | Biotechnology Resource Ce... (1P41EB020594-01), NIH | Cancer Center Support Gra... (3P30CA168524-07S2)

    The role of circulating plasma cells (CPCs) and circulating leukemic cells (CLCs) as biomarkers for several blood cancers, such as multiple myeloma and leukemia, respectively, have recently been reported. These markers can be attractive due to the minimally invasive nat...

    Add to ORCIDorcid
  • publication . Article . 2017
    Closed Access English
    Authors:
    Petroni, K.; Trinei, M.; Fornari, M.; Calvenzani, V.; Marinelli, A.; Micheli, L.A.; Pilu, R.; Matros, A.; Mock, H.-P.; Tonelli, C.; ...
    Persistent Identifiers
    Publisher: Elsevier
    Country: Italy
    Project: EC | ATHENA (245121)

    Abstract Background and aims Anthracyclines are effective anticancer drugs that have improved prognosis of hundred thousand cancer patients worldwide and are currently the most common chemotherapeutic agents used for the treatment of blood, breast, ovarian and lung canc...

    Add to ORCIDorcid
  • publication . Article . 2019
    Open Access English
    Authors:
    Huang, Sixia; Nong, Lin; Liang, Li; Zheng, Yalin; Wang, Wei; Liu, Jumei; Li, Dong; Li, Xin; Wang, Ying; Zhang, Bo; ...
    Persistent Identifiers
    Publisher: John Wiley and Sons Inc.

    Abstract The expression of programmed cell death ligand 1 (PD‐L1) is a biomarker for immunotherapy, but approved detection method is absent in diffuse large B‐cell lymphoma (DLBCL). Here, we performed three methods including immunohistochemistry (IHC) (clone SP263 and S...

    Add to ORCIDorcid
  • publication . Article . 2020
    Open Access English
    Authors:
    Filipe V. Jacinto; Wolfgang Link; Bibiana I. Ferreira;
    Countries: Spain, Portugal
    Project: FCT | UID/BIM/04773/2013 (UID/BIM/04773/2013), EC | TRIBBLES (748585)

    The recent development of the CRISPR/Cas9 system as an efficient and accessible programmable genome‐editing tool has revolutionized basic science research. CRISPR/Cas9 system‐based technologies have armed researchers with new powerful tools to unveil the impact of genet...

    Add to ORCIDorcid
  • publication . Article . 2019
    Restricted
    Authors:
    Dijana Drača; Sanja Mijatović; Tamara Krajnović; Jelena Bogdanović Pristov; Tatjana Đukić; Goran N. Kaluđerović; Ludger A. Wessjohann; Danijela Maksimović-Ivanić;
    Persistent Identifiers
    Publisher: Elsevier BV
    Project: MESTD | Molecular mechanisms of p... (173013)

    Abstract Synthetic tubugis are equally potent but more stable than their natural forms. Their anticancer potential was estimated on a solid melanoma in vitro and in vivo. Tubugi-1 induced the apoptosis in B16 cells accompanied with strong intracellular production of rea...

    Add to ORCIDorcid
  • The cellular glycocalyx of vertebrates is frequently decorated with sialic acid residues. These sialylated structures are recognized by sialic acid-binding immunoglobulin-type lectins (Siglecs) of immune cells, which modulate their responsiveness. Fifteen Siglecs are kn...

    Add to ORCIDorcid
  • publication . Article . 2020
    Authors:
    Lyubomir Haralambiev; Arnab Bandyophadyay; Bettina Suchy; Martin Weiss; Axel Kramer; Sander Bekeschus; Axel Ekkernkamp; Alexander Mustea; Lars Kaderali; Matthias B Stope;
    Persistent Identifiers
    Publisher: Anticancer Research USA Inc.

    Background/aim The antiproliferative effects of cold atmospheric plasma (CAP) make it a promising application option in oncology. The aim of the present study was to examine whether short-term CAP treatment leads to an initial partial elimination of the treated cells or...

    Add to ORCIDorcid
845 research outcomes, page 1 of 85